Advertisement
Advertisement

TRDA

TRDA logo

Entrada Therapeutics, Inc. Common Stock

6.87
USD
Sponsored
0.00
0.00%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

6.86

-0.01
-0.15%

Entrada Therapeutics, Inc. Common Stock Profile

About

Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.

Info & Links

CEO

Dipal Doshi

Headquarters

One Design Center Place, Suite 17-500
Boston, MA 02210, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.entradatx.com

Auditor

Ernst & Young LLP

Share holders

12

Employees

152

Entrada Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

267.11M

Enterprise Value

167.83M

Enterprise Value/EBITDA(ttm)

-0.96

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

57.08

Price to Book(mrq)

1.15

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-3537.73%

Profit Margin(ttm)

-3762.63%

Return on Equity(ttm)

-57.61%

Return on Invested Capital(ttm)

-58.73%

Return on Assets(ttm)

-46.54%

Income Statement

Revenue(ttm)

4.69M

Revenue Per Share(ttm)

0.12

Gross Profit(ttm)

4.69M

EBITDA(ttm)3

-175.13M

Net Income Available to Common(ttm)

-165.78M

Diluted EPS(ttm)

-3.96

Share Statistics

Beta (5Y Monthly)

-0.26

52-Week Change

32.37%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

38.94M

Dividend Yield

0.00%

Float4

35.24M

% Held by Insiders

9.49%

% Held by Institutions

86.39%

Balance Sheet

Total Cash(mrq)

223.00M

Total Cash Per Share(mrq)

5.73

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.89%

Quick Ratio(mrq)

13.90%

Book Value Per Share(mrq)

5.99

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.76

Free Cash Flow(ytd)

-74.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement